Davide Leone & Partners Investment CO Ltd. Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Davide Leone & Partners Investment CO Ltd.

  • $22.9 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$65.78 - $105.02 $1.93 Million - $3.09 Million
-29,395 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$64.07 - $91.75 $665,495 - $953,007
10,387 Added 54.65%
29,395 $2.01 Million
Q4 2020

Feb 16, 2021
BUY
$65.07 - $98.24 $1.24 Million - $1.87 Million
19,008 New
19,008 $1.63 Million

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
785K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.65B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Davide Leone & Partners Investment CO Ltd. Portfolio

Follow Davide Leone & Partners Investment CO Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Davide Leone & Partners Investment CO Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Davide Leone & Partners Investment CO Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email